Avicenna Alliance Members Case Studies on in silico medicine
What can CM&S accomplish? Nothing short of redefining terms like ‘patient safety’, ‘efficacy’ and ‘cost effectiveness’ by forever raising the quality of data needed to meet high standards.
To do this we need to demonstrate what can be already done to give an idea of what we could do in future with the right regulator support and uptake across the healthcare sector.
The case studies in this document give but a glimpse of the potential that has yet to be unleashed by modelling and simulation.
